Also trades as: PNV.AX (ASX) · $vol 2M
CALZF OTC
PolyNovo Limited
1W: +3.0%
1M: +3.5%
3M: +9.5%
YTD: -1.8%
1Y: -16.8%
$0.77
+0.00 (+0.00%)
Weekly Expected Move ±6.1%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$529.4M
52W Range0.55-1.02
Volume19,538
Avg Volume1,157
Beta1.27
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOBruce Peatey
Employees282
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-01-08
Websitepolynovo.com
320 Lorimer Street
Port Melbourne, VIC 3207
AU
Port Melbourne, VIC 3207
AU
61 3 8681 4050
About PolyNovo Limited
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Recent Insider Trades
No insider trades found